当前位置：
X-MOL 学术
›
J. Control. Release
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria
Journal of Controlled Release ( IF 10.8 ) Pub Date : 2024-05-04 , DOI: 10.1016/j.jconrel.2024.04.052 Sofie Meulewaeter , Ilke Aernout , Joke Deprez , Yanou Engelen , Margo De Velder , Lorenzo Franceschini , Karine Breckpot , Serge Van Calenbergh , Caroline Asselman , Katie Boucher , Francis Impens , Stefaan C. De Smedt , Rein Verbeke , Ine Lentacker
Journal of Controlled Release ( IF 10.8 ) Pub Date : 2024-05-04 , DOI: 10.1016/j.jconrel.2024.04.052 Sofie Meulewaeter , Ilke Aernout , Joke Deprez , Yanou Engelen , Margo De Velder , Lorenzo Franceschini , Karine Breckpot , Serge Van Calenbergh , Caroline Asselman , Katie Boucher , Francis Impens , Stefaan C. De Smedt , Rein Verbeke , Ine Lentacker
|
Although various types of mRNA-based vaccines have been explored, the optimal conditions for induction of both humoral and cellular immunity remain rather unknown. In this study, mRNA vaccines of nucleoside-modified mRNA in lipoplexes (LPXs) or lipid nanoparticles (LNPs) were evaluated after administration in mice through different routes, assessing mRNA delivery, tolerability and immunogenicity. In addition, we investigated whether mRNA vaccines could benefit from the inclusion of the adjuvant alpha-galactosylceramide (αGC), an invariant Natural Killer T (iNKT) cell ligand. Intramuscular (IM) vaccination with ovalbumin (OVA)-encoding mRNA encapsulated in LNPs adjuvanted with αGC showed the highest antibody- and CD8 T cell responses. Furthermore, we observed that addition of signal peptides and endocytic sorting signals of either LAMP1 or HLA-B7 in the OVA-encoding mRNA sequence further enhanced CD8 T cell activation although reducing the induction of IgG antibody responses. Moreover, mRNA LNPs with the ionizable lipidoid C12–200 exhibited higher pro-inflammatory- and reactogenic activity compared to mRNA LNPs with SM-102, correlating with increased T cell activation and antitumor potential. We also observed that αGC could further enhance the cellular immunity of clinically relevant mRNA LNP vaccines, thereby promoting therapeutic antitumor potential. Finally, a mRNA LNP vaccine supplemented with αGC showed synergistic protective effects against listeriosis, highlighting a key advantage of co-activating iNKT cells in antibacterial mRNA vaccines. Taken together, our study offers multiple insights for optimizing the design of mRNA vaccines for disease applications, such as cancer and intracellular bacterial infections.
更新日期：2024-05-04
京公网安备 11010802027423号